These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Repeated mismatches may not impair survival of renal regrafts in recipients with 0% to 50% panel reactive antibodies. Mjörnstedt L; Konar J; Skarp I; Olausson M; Sandberg L; Tufvesson G Transplant Proc; 1992 Dec; 24(6):2469. PubMed ID: 1465834 [No Abstract] [Full Text] [Related]
5. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine. Thorogood J; Schreuder GM; Persijn GG; van Rood JJ Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839 [No Abstract] [Full Text] [Related]
6. Azathioprine can be safely stopped in triple drug induction protocols including cyclosporine and steroids in renal transplantation. Pallardó LM; Sánchez J; Sánchez P; García J; Orero E; Beneyto I; Ros F Transplant Proc; 1992 Dec; 24(6):2604-5. PubMed ID: 1465880 [No Abstract] [Full Text] [Related]
7. Analysis of risk factors affecting the outcome of primary living donor renal transplantation in Korea. Park K; Kim YS; Kim SI Transplant Proc; 1992 Dec; 24(6):2426-7. PubMed ID: 1465816 [No Abstract] [Full Text] [Related]
9. Influence of HLA matching on the outcome of kidney transplants in a single center analysis. Schanz D; Blümke M; Keller E; Tanzi-Fetta RF; Kirste G Transplant Proc; 1992 Dec; 24(6):2455. PubMed ID: 1465828 [No Abstract] [Full Text] [Related]
10. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients. Cristol JP; Mourad G; Argiles A; Seignalet J; Iborra F; Ramounau-Pigot A; Chong G; Mion C Transplant Proc; 1992 Dec; 24(6):2470-1. PubMed ID: 1465835 [No Abstract] [Full Text] [Related]
12. Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation. Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds MP; Christiaens R; Gruwez J; Michielsen P Transplant Proc; 1992 Dec; 24(6):2492-3. PubMed ID: 1465841 [No Abstract] [Full Text] [Related]
13. Influence of recipient's HLA type on the outcome of renal transplantation. Forsberg B; Ekberg H; Johnson U Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832 [No Abstract] [Full Text] [Related]
17. DR6 compatibility and kidney graft survival. Correia AM; de Costa AG; Reis P; Rego F; Sampaio MJ; Caetano JM; Pena JR Transplant Proc; 1992 Dec; 24(6):2472. PubMed ID: 1465836 [No Abstract] [Full Text] [Related]
18. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant. Leivestad T; Berger L; Thorsby E Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824 [No Abstract] [Full Text] [Related]
19. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts. Reed E; Cohen DJ; Barr ML; Ho E; Marboe CC; Rose EA; Hardy M; Suciu-Foca N Transplant Proc; 1992 Dec; 24(6):2494-5. PubMed ID: 1465842 [TBL] [Abstract][Full Text] [Related]
20. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related] [Next] [New Search]